Terms: = Breast cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
1358 results:
1. Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature.
Li X; Li X; Yang B; Sun S; Wang S; Yu F; Wang T
Front Immunol; 2024; 15():1369289. PubMed ID: 38756785
[TBL] [Abstract] [Full Text] [Related]
2. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
[TBL] [Abstract] [Full Text] [Related]
3. Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive breast cancer: Mature Results from a Single Institution Experience.
Armstrong S; Makris A; Belessiotis-Richards K; Abdul-Latif M; Ostler P; Shah N; Miles D; Tsang YM
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):362-369. PubMed ID: 38575431
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Values of CD8+, PARP, and EGFR on Overall Survival in Patients with Triple-Negative breast cancer.
Putri RI; Haryono SJ; Brahma B; Prayitno YH; Sutandyo N
Asian Pac J Cancer Prev; 2024 Mar; 25(3):1025-1034. PubMed ID: 38546085
[TBL] [Abstract] [Full Text] [Related]
5. Cost-effective prognostic evaluation of breast cancer: using a STAR nomogram model based on routine blood tests.
Wei C; Liang Y; Mo D; Lin Q; Liu Z; Li M; Qin Y; Fang M
Front Endocrinol (Lausanne); 2024; 15():1324617. PubMed ID: 38529388
[TBL] [Abstract] [Full Text] [Related]
6. In hospital outcomes of autologous and implant-based breast reconstruction in patients with diabetes mellitus: A population-based study of 2015-2020 national inpatient sample.
Li R; Ranganath B
World J Surg; 2024 Apr; 48(4):903-913. PubMed ID: 38498001
[TBL] [Abstract] [Full Text] [Related]
7. Development and Methodological Validation of a Modified staging System for de Novo Metastatic breast cancer.
Berg T; Jensen MB; Rossing M; Bechmann T; Donskov F; Knoop AS; Ejlertsen B
JAMA Netw Open; 2024 Mar; 7(3):e242174. PubMed ID: 38477916
[TBL] [Abstract] [Full Text] [Related]
8. Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study.
Znaor A; Eser S; Bendahhou K; Shelpai W; Al Lawati N; ELBasmi A; Alemayehu EM; Tazi MA; Yakut C; Piñeros M
Int J Cancer; 2024 Jul; 155(1):54-60. PubMed ID: 38456478
[TBL] [Abstract] [Full Text] [Related]
9. A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
Conte B; Brasó-Maristany F; Hernández AR; Pascual T; Villacampa G; Schettini F; Vidal Losada MJ; Seguí E; Angelats L; Garcia-Fructuoso I; Gómez-Bravo R; Lorman-Carbó N; Paré L; Marín-Aguilera M; Martínez-Sáez O; Adamo B; Sanfeliu E; Fratini B; Falato C; Chic N; Vivancos A; Villagrasa P; Staaf J; Parker JS; Perou CM; Prat A
EBioMedicine; 2024 Apr; 102():105043. PubMed ID: 38447275
[TBL] [Abstract] [Full Text] [Related]
10. Predicting the Survival Benefit of Radiotherapy in Elderly breast cancer Patients: A Population-Based Analysis.
Li M; Tang J; Pan X; Zhang D
J Surg Res; 2024 May; 297():26-40. PubMed ID: 38428261
[TBL] [Abstract] [Full Text] [Related]
11. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
[TBL] [Abstract] [Full Text] [Related]
12. Clipping a Positive Lymph Node Improves Accuracy of Nodal staging After Neoadjuvant Chemotherapy for breast cancer Patients, but Does It Drive Management Changes?
Costarelli L; Arienzo F; Broglia L; La Pinta M; Scavina P; Meli EZ; Colavito MH; Ascarelli A; Campagna D; Mastropietro T; Manna E; Amato M; Andrulli AD; Schiavone A; Minelli M; Fortunato L
Ann Surg Oncol; 2024 May; 31(5):3186-3193. PubMed ID: 38427160
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
14. Development and validation of a nomogram for predicting the impact of tumor size on cancer-specific survival of locally advanced renal cell carcinoma: a SEER-based study.
Bai J; Lu Q; Wen Y; Shangguan T; Ye Y; Lin J; Liu R; Cai W; Chen J
Aging (Albany NY); 2024 Feb; 16(4):3823-3836. PubMed ID: 38376430
[TBL] [Abstract] [Full Text] [Related]
15. Bladder-Preserving Trimodality Therapy With Capecitabine.
Lynch C; Sweis RF; Modi P; Agarwal PK; Szmulewitz RZ; Stadler WM; O'Donnell PH; Liauw SL; Pitroda SP
Clin Genitourin Cancer; 2024 Apr; 22(2):476-482.e1. PubMed ID: 38228414
[TBL] [Abstract] [Full Text] [Related]
16. Assignment of the biological value of solid breast masses based on quantitative evaluations of spectral CT examinations using electron density mapping, Zeffective mapping and iodine mapping.
Klein K; Schafigh DG; Wallis MG; Campbell GM; Malter W; Schömig-Markiefka B; Maintz D; Hellmich M; Krug KB
Eur J Radiol; 2024 Feb; 171():111280. PubMed ID: 38219351
[TBL] [Abstract] [Full Text] [Related]
17. Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city population.
Dell'Aquila K; Vadlamani A; Maldjian T; Fineberg S; Eligulashvili A; Chung J; Adam R; Hodges L; Hou W; Makower D; Duong TQ
Breast Cancer Res; 2024 Jan; 26(1):7. PubMed ID: 38200586
[TBL] [Abstract] [Full Text] [Related]
18. Lymphatic remapping by long-term lymphoscintigraphy follow-up in secondary lymphedema after breast cancer surgery.
Hong G; Lee K; Han S; Jeon JY
Sci Rep; 2024 Jan; 14(1):728. PubMed ID: 38184673
[TBL] [Abstract] [Full Text] [Related]
19. Reliability of predicting low-burden (≤ 2) positive axillary lymph nodes indicating sentinel lymph node biopsy in primary operable breast cancer - a retrospective comparative study with PET/CT and breast MRI.
Sae-Lim C; Wu WP; Chang MC; Lai HW; Chen ST; Chou CT; Liao CY; Huang HI; Chen ST; Chen DR; Hung CL
World J Surg Oncol; 2024 Jan; 22(1):12. PubMed ID: 38183069
[TBL] [Abstract] [Full Text] [Related]
20. Targeted axillary dissection: worldwide variations in clinical practice.
Kontos M; Kanavidis P; Kühn T; Masannat Y; Gulluoglu B;
Breast Cancer Res Treat; 2024 Apr; 204(2):389-396. PubMed ID: 38175449
[TBL] [Abstract] [Full Text] [Related]
[Next]
